New hope for Tough-to-Treat breast cancer: trial tests Hormone-Blocking drug
Disease control
Recruiting now
This study is testing if adding a hormone-blocking drug called darolutamide to standard chemotherapy and immunotherapy before surgery works better for a specific type of early-stage, triple-negative breast cancer. About 51 patients with this cancer type will be randomly assigned …
Phase: PHASE2 • Sponsor: Vandana Abramson • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC